# FDA allows temporary import of unapproved Chinese cancer drug to ease U.S. shortage

- Link: https://www.widthness.com/fda-allows-temporary-import-of-unapproved-chinese-cancer-drug-to-ease-u-s-shortage/
- Published: 2023-06-03T10:00:32-05:00
- Author: Curated by Theresa Wysocki

Photo caption: Worker labors on a production line at the factory of Qilu Pharmaceutical in Haikou, Hainan province of China, February 11, 2022. Photo credit: Su Bikun | VCG | Getty Images. Article by Spencer Kimball. CNBC – June 2, 2023. Key Points: The U.S. Food and Drug Administration has given Qilu Pharmaceutical permission to ship cisplatin to the United States to ease a national cancer drug shortage. The drug maker’s cisplatin injections are manufactured and marketed in China. Cisplatin is widely used in chemotherapy to treat testicular, lung, bladder, cervical and ovarian cancers. The FDA earlier said it was considering allowing nonapproved drugs to be imported to alleviate the shortage. […] Click here to view original web page at www.cnbc.com